Modified response to ketoconazole of Candida albicans from a treatment failure. 1983

D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D007654 Ketoconazole Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients. Nizoral,R-41400,R41,400,R41400,R 41400
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002178 Candidiasis, Chronic Mucocutaneous A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy. Candidiases, Chronic Mucocutaneous,Chronic Mucocutaneous Candidiases,Chronic Mucocutaneous Candidiasis,Mucocutaneous Candidiases, Chronic,Mucocutaneous Candidiasis, Chronic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers
May 1985, Medicina clinica,
D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers
May 1989, Canadian journal of surgery. Journal canadien de chirurgie,
D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers
February 1987, Antimicrobial agents and chemotherapy,
D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers
June 1982, Antimicrobial agents and chemotherapy,
D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers
April 1987, Antimicrobial agents and chemotherapy,
D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers
September 2021, Microbiology spectrum,
D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers
April 1985, Medicina clinica,
D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers
January 1987, Mykosen,
D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers
June 1982, Antimicrobial agents and chemotherapy,
D W Warnock, and E M Johnson, and M D Richardson, and C F Vickers
December 1982, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!